|
Wednesday, November 15, 2023
Print Current Session:
 |
|
|
Wednesday
SESSION 32:
CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
|
|
| SESSION 32 SCHEDULE | |
| UPDATE ON RENAL DENERVATION FOR HYPERTENSION | |
| 7:42 AM - 7:47 AM | Update On The Status Of Renal Denervation For Hypertension: It Is Here To Stay: Where Is It Going: Status Of The Radiofrequency Denervation SPYRAL HTN-OFF MED RCT (vs Sham) And Other Catheter-Based Ablative And Ultrasound Methods (The RADIANCE II RCT Findings) |
|
Presenter(s):Eric A. Secemsky, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
| 7:48 AM - 7:53 AM | Multiorgan Denervation For Treatment Of Hypertension, Diabetes And Metabolic Syndrome: How To Do It |
|
Presenter(s):Horst Sievert, MD Location: Grand Ballroom West, 3rd Floor |
|
| 7:54 AM - 7:59 AM | A Precision Medicine Approach To Managing Pediatric Renovascular Hypertension: How Can Medical And Open Surgical Treatment Control It |
|
Presenter(s):Dawn M. Coleman, MD, FACS Location: Grand Ballroom West, 3rd Floor |
|
| OTHER TOPICS RELATED TO VASCULAR DISEASE AND ITS TREATMENT | |
| 8:00 AM - 8:05 AM | How Does The Female Sex Impact The Occurrence Of Lower Extremity Atherosclerosis, Its Treatment And Results Of Treatment |
|
Presenter(s):Katherine A. Gallagher, MD Location: Grand Ballroom West, 3rd Floor |
|
| 8:06 AM - 8:11 AM | How And Why Do Thoracic Endografts For TEVAR Negatively Affect The Blood Pressure And The Heart: Can A Compliant Endograft Prevent The Problem |
|
Presenter(s):Juan C. Parodi, MD Location: Grand Ballroom West, 3rd Floor |
|
| 8:12 AM - 8:17 AM | When Should Smoking Be Stopped Before AAA Repair; Before Lower Extremity Bypass: At Least 4 Weeks: Why Does The Duration Of Cessation Matters |
|
Presenter(s):Jeffrey J. Siracuse, MD, MBA, FACS Location: Grand Ballroom West, 3rd Floor |
|
| 8:18 AM - 8:23 AM | Update On Limiting Transfusion And Permitting Anemia After Major Vascular Operations Increases Mortality And Serious Adverse Events Especially In Patients With Cardiac Co-Morbidities |
|
Presenter(s):Panos Kougias, MD, MSc Location: Grand Ballroom West, 3rd Floor |
|
| 8:24 AM - 8:29 AM | How To Quantitate Late Mortality Risk In Asymptomatic Carotid Stenosis (ACS) Patients: Why It’s Important In Deciding To Treat ACS Patients Non-Invasively |
|
Presenter(s):Stavros K. Kakkos, MD, PhD / Andrew N. Nicolaides, MS, FRCS Location: Grand Ballroom West, 3rd Floor |
|
| 8:30 AM - 8:35 AM | Secondary Prevention Of Vascular Disease And Its Complication With PCSK9 Inhibitors; When They Should Be Used And When Not: How Well Does The New Oral PCSK9 (Inhibitor MK-01616 Work) |
|
Presenter(s):Roxana Mehran, MD Location: Grand Ballroom West, 3rd Floor |
|
| 8:36 AM - 8:41 AM | How Important Is Inflammation As Determined By C-Reactive Protein (CRP) Levels In Predicting Adverse Cardiac Events: What Drugs Can Lower This Risk |
|
Presenter(s):Ron Waksman, MD Location: Grand Ballroom West, 3rd Floor |
|
| 8:42 AM - 8:50 AM | Panel Discussion |
| 8:50 AM - 9:06 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 32 | |
| previous | next |